PAR 0.00% 30.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigm Receives $7.36m R&D Tax Incentive Refund, page-51

  1. 102 Posts.
    lightbulb Created with Sketch. 28
    I believe the dosgae used for the phase 2B was the 2x2, moz can probably chime in on patient numbers as I cant re-call off the top of my head. There was prior art for 1.5 and this is what the FDA based their decision off. From their risk mitigation perspective, there is no point risking the 2x2 on a large scale (P3) if the 1.5 was just as effective.
    I do agree with you, that it was a nice big waste of time and money.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.5¢
Change
0.000(0.00%)
Mkt cap ! $106.6M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 15174 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 500 1
View Market Depth
Last trade - 09.43am 18/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.